Filing Details
- Accession Number:
- 0001104659-18-019665
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-22 21:01:08
- Reporting Period:
- 2018-03-20
- Accepted Time:
- 2018-03-22 21:01:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1621227 | Adaptimmune Therapeutics Plc | ADAP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1555851 | Adrian Rawcliffe | 440 South Broad Street, Unit 2203 Philadelphia PA 19146 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2018-03-20 | 600,000 | $1.71 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The Ordinary Shares whose sale is reported on this line are represented by American Depositary Shares ("ADSs"). Each ADS represents six Ordinary Shares. The Ordinary Shares were obtained from the partial exercise of an option that was granted on March 16, 2015.
- The sale price of $1.71 per Ordinary Share was derived from the sale price of $10.27 per ADS on March 20, 2018 divided by six.
Billionaire Hedge Funds
